Boron-containing small molecules
US-2015119364-A1 · Apr 30, 2015 · US
US9572823B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9572823-B2 |
| Application number | US-201615091394-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 5, 2016 |
| Priority date | Feb 16, 2005 |
| Publication date | Feb 21, 2017 |
| Grant date | Feb 21, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
This invention relates to compounds useful for treating fungal infections, more specifically topical treatment of onychomycosis and/or cutaneous fungal infections. This invention is directed to compounds that are active against fungi and have properties that allow the compound, when placed in contact with a patient, to reach the particular part of the skin, nail, hair, claw or hoof infected by the fungus. In particular the present compounds have physiochemical properties that facilitate penetration of the nail plate.
Opening claim text (preview).
What is claimed is: 1. A method of delivering a compound, in a human, from a dorsal layer of a nail plate to a nail bed to treat onychomycosis caused by Trichophyton rubrum or Trichophyton mentagrophytes , the method comprising: contacting the dorsal layer of the nail plate with a pharmaceutical composition comprising a compound that penetrates the nail plate, the compound being 1,3-dihydro-5-fluoro-1-hydroxy-2,1-benzoxaborole or a pharmaceutically acceptable salt thereof, thereby treating onychomycosis due to Trichophyton rubrum or Trichophyton mentagrophytes. 2. The method of claim 1 , wherein the pharmaceutical composition is in the form of a topical solution comprising 5% w/w of 1,3-dihydro-5-fluoro-1-hydroxy-2,1-benzoxaborole, and wherein the pharmaceutical composition further comprises ethanol and propylene glycol. 3. The method of claim 1 , wherein the pharmaceutical composition further comprises ethanol and propylene glycol. 4. The method of claim 1 , wherein the contacting of the dorsal layer of the nail plate with the pharmaceutical composition occurs once a day. 5. The method of claim 1 , wherein a cause of the onychomycosis is due to Trichophyton rubrum. 6. The method of claim 1 , wherein a cause of the onychomycosis is due to Trichophyton mentagrophytes.
Antimycotics · CPC title
Boron compounds · CPC title
Boronic and borinic acid compounds · CPC title
Drugs for dermatological disorders · CPC title
Compounds containing boron, silicon or a metal, e.g. chelates or vitamin B12 (esters with inorganic acids C07H11/00) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.